Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00304434 · ClinicalTrials.gov registry record · Phase 4

Evaluation of Alternative Oseltamivir (Tamiflu) Dosing Strategies.

A Phase 4 study, sponsored by US Department of Veterans Affairs.

Completed
Registry status
Phase 4
Development phase
48
Enrollment target

NCT00304434: Completed Phase 4 study, sponsored by US Department of Veterans Affairs.

NCT00304434 is a Phase 4 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 48 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00304434, a Phase 4 study, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
Phase 4
Development phase
48 participants
Enrollment target

Study Summary

Objective 1: Determine the safety and toxicity profile of Tamiflu administered in combination with probenecid in healthy adults.Objective 2: Determine the pharmacokinetic profile of Tamiflu and probenecid in healthy adults.

Interventions

  • DRUG Probenecid
  • DRUG Oseltamivir

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2005-02
Est. Completion 2007-02
Phase Phase 4
US Department of Veterans Affairs

632 total trials

What the finished NCT00304434 record still lists

NCT00304434 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 2 interventions - of which Probenecid is the first listed.

NCT00304434 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00304434 about?

NCT00304434 is a clinical study titled "Evaluation of Alternative Oseltamivir (Tamiflu) Dosing Strategies.". Objective 1: Determine the safety and toxicity profile of Tamiflu administered in combination with probenecid in healthy adults.Objective 2: Determine the pharmacokinetic profile of Tamiflu and probenecid in healthy adults.

What is the current status of trial NCT00304434?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 48 participants. The study started on 2005-02. Estimated completion is 2007-02.

What interventions are being tested in trial NCT00304434?

The interventions under investigation include: Probenecid (DRUG), Oseltamivir (DRUG).

Who is sponsoring clinical trial NCT00304434?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00304434's enrollment target sits among peer trials

48 1331st of 2000 higher than 653 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01765777 · 48 participants · NA

    Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain

  • NCT03073343 · 48 participants · NA

    A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

  • NCT03431064 · 48 participants

    Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients

  • NCT03514602 · 48 participants · NA

    Maternal Smoking Cessation and Pediatric Obesity Prevention

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00304434, the US trial registry maintained by the National Library of Medicine. NCT00304434 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.